Pseudomonas aeruginosa causing nosocomial meningitis in neonates and children: overview of 15 cases within 10 years

A Ondrusova; E Kalavsky; B Rudinsky; F P Freybergh; F Bauer; Jozef Miklosko; M Huttova; P Kisac; R Cauda

Pseudomonas aeruginosa causing nosocomial meningitis in neonates and children: overview of 15 cases within 10 years

Neuro Endocrinol Lett. 2007 Jun:28 Suppl 2:20-1.

Authors

A Ondrusova¹, E Kalavsky, B Rudinsky, F P Freybergh, F Bauer, Jozef Miklosko, M Huttova, P Kisac, R Cauda

Affiliation

¹ Clinic of Tropical Infectious Diseases, St. Lesley, Strattmann Clinic of St. Elisabeth University College, Eldoret, Kenya.

PMID: 17558370

Abstract

Risk factors, therapy and outcome of 15 cases of nosocomial meningitis due to Pseudomonas aeruginosa is reviewed. No difference in risk factors was found, however mortality for Ps. aeruginosa was significantly higher (33.3 vs 15.1% p<0.04).

MeSH terms

Adolescent
Anti-Bacterial Agents / therapeutic use*
Cefotaxime / therapeutic use
Ceftazidime / therapeutic use
Chi-Square Distribution
Child, Preschool
Chloramphenicol / therapeutic use
Cross Infection / drug therapy
Cross Infection / microbiology*
Cross Infection / mortality
Drug Therapy, Combination
Female
Gentamicins / therapeutic use
Humans
Infant
Infant, Newborn
Male
Meningitis, Bacterial / drug therapy
Meningitis, Bacterial / microbiology*
Meningitis, Bacterial / mortality
Meropenem
Pseudomonas Infections / drug therapy
Pseudomonas Infections / mortality*
Retrospective Studies
Risk Factors
Survival Analysis
Thienamycins / therapeutic use

Substances

Anti-Bacterial Agents
Gentamicins
Thienamycins
Chloramphenicol
Ceftazidime
Meropenem
Cefotaxime